Lu Han
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
Papers in ⓘ
-
- MicroRNA in disease regulation 7
-
- Nanoparticle-Based Drug Delivery 6
- Co-authors
- Tao Gong (4 shared papers)Sanjun Shi (3 shared papers)Xun Sun (4 shared papers)Zhixiang Yuan (7 shared papers)Zhirong Zhang (4 shared papers)Zhirong Zhang (2 shared papers)Rong Wang (2 shared papers)Chunai Gong (2 shared papers)
- Journals
- Optics Express (2 papers)ACS Applied Materials & Interfaces (2 papers)Colloids and Surfaces B Biointerfaces (2 papers)Journal of Nanobiotechnology (2 papers)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Lu Han
43 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 125
- Biomaterials 277
- Pharmaceutical Science 84
- Cancer Research 203
- Oncology 244
- Immunology 186
Countries citing papers authored by Lu Han
This map shows the geographic impact of Lu Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Han more than expected).
Fields of papers citing papers by Lu Han
This network shows the impact of papers produced by Lu Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Han. The network helps show where Lu Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 158 | |
| 2 | 2014 | 140 | |
| 3 | Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics | 2022 | 107 |
| 4 | 2013 | 100 | |
| 5 | 2013 | 83 | |
| 6 | 2014 | 75 | |
| 7 | 2018 | 54 | |
| 8 | 2021 | 49 | |
| 9 | 2021 | 44 | |
| 10 | 2017 | 40 | |
| 11 | 2016 | 38 | |
| 12 | 2012 | 29 | |
| 13 | 2022 | 29 | |
| 14 | 2021 | 27 | |
| 15 | 2021 | 25 | |
| 16 | 2017 | 24 | |
| 17 | 2023 | 19 | |
| 18 | 2019 | 16 | |
| 19 | 2023 | 16 | |
| 20 | 2023 | 14 |
About Lu Han
Lu Han is a scholar working on Cancer Research, Biomaterials, Molecular Medicine, Polymers and Plastics and Transportation, having authored 50 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), MicroRNA in disease regulation (7 papers), Nanoplatforms for cancer theranostics (6 papers), Nanoparticle-Based Drug Delivery (6 papers), Advanced Sensor and Energy Harvesting Materials (6 papers), Extracellular vesicles in disease (5 papers), Cancer Cells and Metastasis (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Biomaterials (277 citations), Pharmaceutical Science (84 citations), Cancer Research (203 citations), Oncology (244 citations) and Immunology (186 citations). Lu Han has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Tao Gong, Sanjun Shi, Xun Sun, Zhixiang Yuan, Zhirong Zhang, Zhirong Zhang, Rong Wang, Chunai Gong, Lili He and Xun Sun. Their work appears in journals such as Optics Express, ACS Applied Materials & Interfaces, Colloids and Surfaces B Biointerfaces, Journal of Nanobiotechnology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.